aHypertensie en Cardiovasculaire Revalidatie Eenheid, Departement voor Moleculair en Cardiovasculair Onderzoek, Katholieke Universiteit Leuven, Leuven, Belgium, bCattedra e Scuola di Nefrologia, Università Vita e Salute San Raffaele, Milano, Italy and cDepartment of Physiology, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
Sponsorship: The FLEMENGHO study was supported by research grants G.0291.98 and G.0424.03 from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (Brussels, Belgium), the Bilateral Scientific and Technical Collaboration between Flanders and China (project BIL02/10), a special research grant from the University of Leuven (Onderzoekstoelage OT99/28), a grant from the Ministero della Sanità (Milan, Italy) to Giuseppe Bianchi (RF200-00-49), and funds from the European Union (contract number IC15-CT98-0329-EPOGH and QLG1-CT-2000-01137-EURNETGEN).
Correspondence and requests for reprints to Dr Jan A. Staessen, Study Coordinating Centre, Laboratory of Hypertension, Department of Molecular and Cardiovascular Research, Campus Gasthuisberg, University of Leuven, Herestraat 49, B-3000 Leuven, Belgium. Tel: +32 16 34 7104; fax: +32 16 34 7106; e-mail: [email protected]
Received 7 February 2003 Revised 15 April 2003 Accepted 28 April 2003
